See more : OMV Aktiengesellschaft (OMV.VI) Income Statement Analysis – Financial Results
Complete financial analysis of Intuitive Surgical, Inc. (ISRG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Intuitive Surgical, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- New Horizon Group, Inc. (NHGP) Income Statement Analysis – Financial Results
- GreenTech Metals Limited (GRE.AX) Income Statement Analysis – Financial Results
- The Market Herald Limited (TMH.AX) Income Statement Analysis – Financial Results
- Tenaga Nasional Berhad (5347.KL) Income Statement Analysis – Financial Results
- Everest Kanto Cylinder Limited (EKC.NS) Income Statement Analysis – Financial Results
Intuitive Surgical, Inc. (ISRG)
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B | 2.38B | 2.13B | 2.27B | 2.18B | 1.76B | 1.41B | 1.05B | 874.92M | 600.83M | 372.68M | 227.34M | 138.80M | 91.68M | 72.02M | 51.67M | 26.62M | 10.19M | 0.00 |
| Cost of Revenue | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.80M | 814.30M | 806.50M | 717.90M | 670.90M | 608.50M | 483.50M | 383.00M | 301.12M | 254.14M | 186.54M | 124.85M | 73.77M | 50.81M | 47.65M | 34.58M | 28.22M | 13.28M | 7.03M | 0.00 |
| Gross Profit | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.19B | 1.89B | 1.58B | 1.41B | 1.59B | 1.57B | 1.27B | 1.03B | 751.05M | 620.78M | 414.29M | 247.84M | 153.57M | 87.99M | 44.03M | 37.44M | 23.46M | 13.35M | 3.16M | 0.00 |
| Gross Profit Ratio | 66.39% | 67.44% | 69.32% | 65.65% | 69.45% | 69.92% | 70.12% | 69.89% | 66.18% | 66.32% | 70.38% | 72.07% | 72.49% | 72.89% | 71.38% | 70.95% | 68.95% | 66.50% | 67.55% | 63.39% | 48.03% | 51.98% | 45.39% | 50.12% | 31.02% | 0.00% |
| Research & Development | 998.80M | 879.00M | 671.00M | 595.10M | 557.30M | 418.10M | 328.60M | 239.60M | 197.40M | 178.00M | 167.70M | 170.00M | 140.20M | 116.00M | 95.10M | 79.37M | 48.86M | 29.78M | 17.35M | 17.81M | 16.19M | 16.79M | 13.85M | 11.73M | 11.13M | 23.21M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.60M | 810.90M | 705.30M | 640.50M | 691.00M | 574.00M | 522.20M | 438.80M | 358.80M | 278.51M | 230.57M | 158.69M | 110.70M | 67.44M | 48.99M | 39.72M | 40.86M | 29.99M | 19.14M | 9.34M | 7.57M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.75M | 11.58M | 7.57M |
| Operating Expenses | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 944.90M | 837.90M | 869.00M | 741.70M | 692.20M | 579.00M | 474.80M | 373.61M | 309.94M | 207.54M | 140.48M | 84.80M | 66.81M | 55.91M | 57.66M | 43.84M | 35.62M | 22.71M | 30.77M |
| Cost & Expenses | 5.36B | 4.65B | 3.89B | 3.31B | 3.10B | 2.52B | 2.07B | 1.76B | 1.64B | 1.59B | 741.70M | 1.30B | 1.06B | 857.80M | 674.73M | 564.08M | 394.09M | 265.33M | 158.57M | 117.62M | 103.56M | 92.24M | 72.06M | 48.90M | 29.74M | 30.77M |
| Interest Income | 192.10M | 29.70M | 69.30M | 157.20M | 116.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 29.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 421.80M | 380.40M | 317.00M | 282.50M | 199.70M | 120.10M | 95.00M | 88.90M | 89.50M | 74.40M | 67.30M | 57.80M | 46.50M | 40.40M | 34.58M | 25.08M | 13.03M | 35.27M | 6.73M | 7.11M | 10.63M | 4.55M | 4.71M | 4.75M | 2.24M | 0.00 |
| EBITDA | 2.17B | 1.58B | 1.82B | 1.05B | 1.37B | 1.32B | 1.16B | 1.05B | 740.00M | 619.20M | 919.80M | 935.90M | 741.30M | 595.60M | 377.44M | 335.92M | 219.77M | 107.36M | 75.50M | 21.18M | -1.25M | -15.67M | -15.67M | -17.53M | -17.31M | -30.77M |
| EBITDA Ratio | 30.45% | 25.35% | 31.89% | 24.09% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 38.39% | 36.58% | 38.27% | 33.44% | 20.21% | -1.79% | -21.70% | -30.41% | -65.42% | -169.80% | 0.00% |
| Operating Income | 1.77B | 1.21B | 1.82B | 773.60M | 1.37B | 1.20B | 1.05B | 945.20M | 740.00M | 544.80M | 852.50M | 878.10M | 694.80M | 555.20M | 377.44M | 310.84M | 206.74M | 107.36M | 68.77M | 21.18M | -11.88M | -20.22M | -20.38M | -22.28M | -19.55M | -30.77M |
| Operating Income Ratio | 24.80% | 19.47% | 31.89% | 17.75% | 30.69% | 32.21% | 33.71% | 34.95% | 31.04% | 25.56% | 37.64% | 40.30% | 39.54% | 39.29% | 35.87% | 35.53% | 34.41% | 28.81% | 30.25% | 15.26% | -12.96% | -28.07% | -39.45% | -83.67% | -191.81% | 0.00% |
| Total Other Income/Expenses | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M | 18.50M | 4.20M | 18.40M | 15.80M | 14.90M | 17.10M | 18.67M | 24.37M | 30.49M | 12.78M | 5.04M | 3.02M | 2.26M | 1.80M | 42.00K | -108.00K | 0.00 | 0.00 |
| Income Before Tax | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 980.80M | 758.50M | 549.00M | 870.90M | 893.90M | 709.70M | 572.30M | 396.11M | 335.20M | 237.23M | 120.14M | 73.81M | 24.20M | -9.62M | -18.42M | -20.34M | -22.39M | 0.00 | 0.00 |
| Income Before Tax Ratio | 27.50% | 25.82% | 33.10% | 27.69% | 33.54% | 34.36% | 35.04% | 36.27% | 31.81% | 25.75% | 38.45% | 41.03% | 40.39% | 40.50% | 37.65% | 38.31% | 39.48% | 32.24% | 32.47% | 17.44% | -10.50% | -25.58% | -39.36% | -84.08% | 0.00% | 0.00% |
| Income Tax Expense | 141.60M | 262.40M | 162.20M | 140.20M | 120.40M | 154.50M | 436.50M | 244.90M | 169.70M | 130.20M | 199.90M | 237.30M | 214.60M | 190.50M | 163.51M | 130.89M | 92.70M | 48.09M | -20.33M | 726.00K | -2.26M | -1.80M | -3.68M | -3.75M | -1.13M | 29.44M |
| Net Income | 1.80B | 1.32B | 1.70B | 1.06B | 1.38B | 1.13B | 660.00M | 735.90M | 588.80M | 418.80M | 671.00M | 656.60M | 495.10M | 381.80M | 232.61M | 204.32M | 144.54M | 72.04M | 94.13M | 23.48M | -9.62M | -18.42M | -16.70M | -18.52M | -18.42M | -29.44M |
| Net Income Ratio | 25.24% | 21.25% | 29.85% | 24.33% | 30.80% | 30.29% | 21.09% | 27.21% | 24.69% | 19.65% | 29.62% | 30.14% | 28.17% | 27.02% | 22.11% | 23.35% | 24.06% | 19.33% | 41.41% | 16.91% | -10.50% | -25.58% | -32.32% | -69.57% | -180.68% | 0.00% |
| EPS | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 | 1.76 | 1.26 | 1.86 | 1.83 | 1.40 | 1.08 | 0.67 | 0.58 | 0.42 | 0.22 | 0.30 | 0.08 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| EPS Diluted | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 | 2.08 | 1.73 | 1.23 | 1.86 | 1.78 | 1.37 | 1.05 | 0.66 | 0.57 | 0.41 | 0.21 | 0.28 | 0.07 | -0.05 | -0.11 | -0.10 | -0.17 | -0.85 | -1.81 |
| Weighted Avg Shares Out | 351.20M | 355.70M | 356.10M | 351.00M | 346.20M | 341.10M | 335.10M | 344.70M | 333.90M | 332.10M | 360.97M | 358.20M | 352.80M | 352.80M | 344.68M | 349.89M | 340.48M | 330.63M | 315.63M | 303.24M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
| Weighted Avg Shares Out (Dil) | 357.40M | 362.00M | 365.80M | 360.90M | 358.50M | 356.40M | 348.90M | 353.70M | 341.10M | 339.30M | 360.97M | 369.90M | 361.80M | 362.70M | 352.85M | 359.49M | 351.19M | 342.84M | 337.39M | 314.78M | 212.63M | 164.06M | 161.17M | 107.08M | 21.77M | 16.29M |
Inflation Cools in July: 4 Sector ETFs & Stocks to Thrive
The annual inflation rate in the United States slowed for a fourth successive month in July 2024.
The 3 Best Robotics Stocks to Buy in August 2024
Now could be a great time for investors to consider the best robotics stocks to buy in August. I wrote around a month ago that there could be record volatility in the market.
Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
In a market characterized by uncertainty and volatility, it's increasingly rare to find stocks that are weathering the storm and thriving. Yet, a select few from various sectors are doing just that—hitting all-time highs even as the broader market indices...
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
3 Robotics Stocks Poised for Possible Industrial Revolution
Now might be a great time for investors to consider scooping up shares of these robotics stocks. I think that although in the short-term these technologies will be a slow burn in terms of improving company productivity, the tech stack...
Can Intuitive Surgical (ISRG) Run Higher on Rising Earnings Estimates?
Intuitive Surgical (ISRG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
13 stocks to consider if you're able to brave recession fears
Now that stock investors are beginning to realize that a recession isn't on the way, the U.S. market will get back to doing what is up to before the August swoon: showing strength beyond the Magnificent Seven.
What's Up Next for Intuitive Surgical Stock?
Intuitive Surgical is sailing against a few new headwinds. So far its financial performance hasn't been severely impacted.
This Robotics-Assisted Surgery Leader Just Posted Stellar Earnings. Is It A Buy?
Intuitive Surgical's da Vinci robots help doctors perform surgeries with fewer errors. Procedure growth is impressive, driving revenue for the company's instruments and accessories.
Intuitive Surgical (ISRG) Rises 5% Post Earnings: What's Next?
Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.
Source: https://incomestatements.info
Category: Stock Reports